Hydrochloric Acid

Hydrochloric Acid

SCHEMBL2901359

Fc1c(F)c(F)c(-c2c3nc(c(-c4c(F)c(F)c(F)c(F)c4F)c4ccc([nH]4)c(-c4c(F)c(F)c(F)c(F)c4F)c4nc(c(-c5c(F)c(F)c(F)c(F)c5F)c5ccc2[nH]5)C=C4)C=C3)c(F)c1F.[Cl-].[Cl-].[Cl-].[Fe+3]

nearest known ligand 0.86

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ TOP1 P11387 2/20 0.45
▸ TERT O14746 4/20 0.45
▸ CYCS P99999 2/20 0.42
▸ ENPP2 Q13822 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6865971 0.96 TOP1 (0.45) TOP1TERTCYCSENPP2
Hydrochloric Acid SCHEMBL29939540 0.96 TOP1 (0.45) TOP1TERTCYCSENPP2
Hydrochloric Acid SCHEMBL21493256 0.96 TOP1 (0.45) TOP1TERTCYCSENPP2
Hydrochloric Acid SCHEMBL30558880 0.96 TOP1 (0.45) TOP1TERTCYCSENPP2
SCHEMBL174717 0.96 TERT (0.47) TOP1TERTCYCSENPP2
SCHEMBL29353372 0.96 TERT (0.47) TOP1TERTCYCSENPP2
SCHEMBL29582816 0.96 TERT (0.47) TOP1TERTCYCSENPP2
SCHEMBL29648942 0.96 TERT (0.47) TOP1TERTCYCSENPP2
SCHEMBL1313450 0.94 TERT (0.46) TOP1TERTCYCSENPP2
SCHEMBL4020034 0.94 TERT (0.46) TOP1TERTCYCSENPP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120122706-A1 ARRAY USING COLOR REACTION OF CHEMICAL COMPOUNDS ELECTRONICS AND TELECOMMUNICATIONS RESEARCH INSTITUTE (KR) 2012-05-17 — — US claimed
US-7297657-B2 Process for the preparation of N-(phosphonomethyl)glycine by oxidizing N-substituted N-(phosphonomethyl)glycine MONSANTO TECHNOLOGY LLC (US) 2007-11-20 — — US claimed
EP-1716923-A1 Oxidation catalyst for making glyphosate Monsanto Technology, LLC (US) 2006-11-02 — — EP claimed
EP-1062221-B1 PROCESS FOR MAKING GLYPHOSATE BY OXIDIZING N-SUBSTITUTED GLYPHOSATES MONSANTO TECHNOLOGY LLC (US) 2006-05-10 — — EP claimed
US-20040143134-A1 Process for the preparation of N-(phosphonomethyl)glycine by oxidizing N-substituted N-(phosphonomethyl)glycine MONSANTO TECHNOLOGY LLC 2004-07-22 — — US claimed
US-20010018536-A1 Process for the preparation of n- (phosphonomethyl) glycine by oxidizing n-substituted n-(phosphonomethyl) glycine MONSANTO TECHNOLOGY LLC 2001-08-30 — — US claimed
US-6232494-B1 CATALYTIC OXIDATION MONSANTO COMPANY 2001-05-15 — — US claimed
US-6005140-A USING A NOBLE METAL OXIDATION CATALYST MONSANTO COMPANY (US) 1999-12-21 — — US claimed
CN-117783019-A On-site detection method of CTC black tea production place based on solution phase color sensing array 安徽农业大学 2024-03-29 — — CN disclosed
CN-106290631-B A kind of method of pigment array sensing technology Fast Evaluation magma Quality of Liquors 江苏今世缘酒业股份有限公司 2018-11-27 — — CN disclosed
EP-2057275-B1 ARRAY FOR RAPID DETECTION OF A MICROORGANISM KIMBERLY CLARK CO (US) 2017-02-01 — — EP disclosed
CN-106290631-A A kind of method of pigment array sensing technology Fast Evaluation original plasm wine quality 江苏今世缘酒业股份有限公司 2017-01-04 — — CN disclosed
EP-2331952-B1 COLORIMETRIC SENSOR ARRAYS BASED ON NANOPOROUS PIGMENTS UNIV ILLINOIS (US) 2016-06-15 — — EP disclosed
EP-2056890-B1 METHOD FOR DETECTING CANDIDA ON SKIN KIMBERLY CLARK CO (US) 2015-11-18 — — EP disclosed
US-6153753-A CATALYTIC CARBOXYMETHYLATION OF A CARBAMOYL COMPOUND BY PREMIXING THE CARBAMOYL COMPOUND AND THE CARBOXYMETHYLATION CATALYST PRECURSOR FIRST, THEN ADDING THE WATER AND ALDEHYDE; FORMING N-(PHOSPHONOMETHYL)GLYCINE HERBICIDE OR PESTICIDE MONSANTO COMPANY (US) 2000-11-28 — — US disclosed
US-6005140-A USING A NOBLE METAL OXIDATION CATALYST MONSANTO COMPANY (US) 1999-12-21 — — US disclosed
US-5981422-A PERFLUOROALKYLPHTHALOCYANINATO METAL COMPLEX OR 20-TETRAKIS-PENTAFLUOROPHENYL PORPHYRIN METAL COMPLEX USED AS CATALYST EXXON RESEARCH AND ENGINEERING CO. (US) 1999-11-09 — — US disclosed
EP-0633062-B1 Fluorous multiphase catalyst or reagent systems, and processes using them EXXON RESEARCH ENGINEERING CO (US) 1999-09-08 — — EP disclosed
US-5463082-A Fluorous multiphase systems EXXON RESEARCH AND ENGINEERING COMPANY (US) 1995-10-31 — — US disclosed
EP-0633062-A1 Fluorous multiphase catalyst or reagent systems, and processes using them EXXON RESEARCH AND ENGINEERING COMPANY (US) 1995-01-11 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010018536-A1 Process for the preparation of n- (phosphonomethyl) glycine by oxidizing n-substituted n-(phosphonomethyl) glycine GNMT, GRHPR, GLRA3 TOP1 3870/4885TERT 3782/4885CYCS 865/4885
US-20040143134-A1 Process for the preparation of N-(phosphonomethyl)glycine by oxidizing N-substituted N-(phosphonomethyl)glycine GNMT, GRHPR, GLRA3 TOP1 3845/4885TERT 3877/4885CYCS 858/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback